Five-year results from the randomized REDUCE trial show a continued benefit of patent foramen ovale (PFO) closure compared with antiplatelet therapy alone for the prevention of cryptogenic stroke.
New data on infective endocarditis (IE) among people who inject drugs run counter to long-held stereotypes about the condition—for example, a sizeable proportion of cases affect the heart’s left side, occur in prosthetic valves, and arise from organisms other than Staphylococcus aureus.
While not intended to coincide with COVID-19, the timing of the document is “fortuitous,” given the shortage of hospital beds.
Combining PCI and TAVR significantly increases the risk of bleeding compared with a coronary intervention alone, and that excess hazard is not captured well by the CathPCI risk model, data from a large New York City hospital show.
Greater sodium intake on a national level is associated with a longer average life expectancy and reduced all-cause mortality, according to an ecological study based on data from 181 countries.
Morton Kern, MD, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in cardiology.
The anti-inflammatory may improve outcomes after effective drainage of fluid, an observational study suggests.
Medicare data confirm IE post-TAVR is decreasing in recent years, while another report hints TAVR itself could—in select cases—treat IE.
Mirroring other cohorts around the globe, US patients hospitalized with COVID-19 experience a high rate of cardiovascular events, but careful chart review suggests that these same patients also have a high burden of cardiovascular risk factors to begin with, according to research presented during the virtual European Society of Cardiology (ESC) Congress 2020.
MIS-C and an adult myocarditis-like syndrome are likely on a shared spectrum of CV complications, researchers say.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!